首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1634198

全球脑电图设备市场 - 2025 - 2033

Global Electroencephalography Devices Market - 2025 - 2033

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年，全球脑电图设备市场达到14.8亿美元，预计2033年将达到30.8亿美元，2025-2033年预测期间复合年增长率为7.4%。

脑电图 (EEG) 是一种无痛测试，使用附着在头皮上的小型感测器记录大脑活动。这些讯号由医生（通常是临床神经生理学家）进行分析。脑电图可以帮助诊断和监测各种脑部疾病，例如导致反覆癫痫发作的癫痫症。脑电图的主要用途是检测和调查癫痫，帮助医生确定癫痫的类型、诱因以及患者的最佳治疗方案。此程序通常由训练有素的专家在医院就诊期间进行。

市场动态：

驱动程式和限制

科技进步的崛起

技术进步彻底改变了脑电波资料撷取、分析和利用，成为全球脑电图 (EEG) 设备市场的重要驱动因素之一。无线和穿戴式脑电图设备增强了便携性和用户便利性，能够在临床和非临床环境中进行即时监测。高密度脑电图系统和改进的感测器技术提高了大脑活动映射的准确性，从而实现更好的神经诊断。人工智慧和机器学习演算法的整合改变了资料解释，从而能够更快、更精确地分析复杂的神经状况。基于云端的资料储存和支援物联网的设备拓宽了脑电图技术在远距医疗、游戏和认知研究领域的应用。

例如，2024 年 4 月，Soterix Medical 推出了 MxN-GO EEG，这是一种组合式高清经颅电刺激 (HD-tES) 和 EEG 系统，专为行动和自然环境中的研究应用而设计。轻巧的无线系统提供 33 个刺激通道和 32 个记录通道，提供无与伦比的精确度和特定于应用的定位。该系统与 mBrainTrain 合作开发，旨在快速设定和易于使用，为行动混合刺激/脑电图研究提供终极解决方案。

缺乏熟练的专业人员

由于缺乏熟练的专业人员，限制了先进技术的充分利用，全球脑电图（EEG）设备市场面临挑战。准确的脑电图记录和分析需要电极放置、讯号收集和解释复杂脑电波资料的专业知识，而这在医疗保健环境中通常是不可用的，尤其是在新兴市场。这种短缺影响了癫痫和睡眠障碍等神经系统疾病的诊断准确性，并影响了依赖脑电图资料的研究计划。

有关此报告的更多详细资讯 - 索取样品

An electroencephalogram (EEG) is a painless test that records brain activity using small sensors attached to the scalp. These signals are analyzed by a doctor, usually a clinical neurophysiologist. EEGs can help diagnose and monitor various brain conditions, such as epilepsy, which causes repeated seizures. The main use of EEGs is to detect and investigate epilepsy, helping doctors identify the type of epilepsy, triggers, and the best treatment for the patient. The procedure is usually carried out by a highly trained specialist during a hospital visit.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

Technological advancements are one of the significant driving factors in the Global Electroencephalography (EEG) Devices Market by revolutionizing brainwave data capture, analysis, and utilization. Wireless and wearable EEG devices enhance portability and user convenience, enabling real-time monitoring in clinical and non-clinical settings. High-density EEG systems and improved sensor technology improve brain activity mapping accuracy, enabling better neurological diagnosis. The integration of AI and machine learning algorithms transforms data interpretation, enabling faster, more precise analysis for complex neurological conditions. Cloud-based data storage and IoT-enabled devices broaden EEG technology's application across telemedicine, gaming, and cognitive research.

For instance, in April 2024, Soterix Medical has launched the MxN-GO EEG, a combined High Definition transcranial Electrical Stimulation (HD-tES) and EEG system designed for research applications in mobile and natural environments. The lightweight, wire-free system offers 33 stimulation channels and 32 recording channels, providing unparalleled precision and application-specific targeting. The system, developed in collaboration with mBrainTrain, is designed for rapid set-up and ease of use, offering the ultimate solution for mobile hybrid stimulation/EEG studies.

Lack of Skilled Professionals

The Global Electroencephalography (EEG) Devices Market faces challenges due to a shortage of skilled professionals, limiting the full utilization of advanced technologies. Accurate EEG recording and analysis require expertise in electrode placement, signal acquisition, and interpreting complex brainwave data, which is often unavailable in healthcare settings, especially in emerging markets. This shortage hampers diagnostic accuracy for neurological conditions like epilepsy and sleep disorders and affects research initiatives relying on EEG data.

For more details on this report - Request for Sample

Segment Analysis

The global electroencephalography devices market is segmented based on product type, application, technology, end user and region.

Product Type:

Portable EEG Devices segment is expected to dominate the Electroencephalography Devices market share

The portable EEG devices segment holds a major portion of the electroencephalography devices market share and is expected to continue to hold a significant portion of the electroencephalography devices market share during the forecast period.

Portable EEG devices are revolutionizing the Global Electroencephalography (EEG) Devices Market by providing accessibility and convenience in neurological diagnostics and monitoring. These devices are designed for mobility, allowing patients to undergo testing outside traditional clinical settings, particularly for conditions like epilepsy, sleep disorders, and brain injuries. Equipped with advanced wireless technologies, they enable real-time data transmission and integration with digital platforms for analysis and storage. Their compact design and user-friendly interfaces make them suitable for telemedicine applications, expanding their reach to underserved or remote areas.

For instance, in April 2024, NeuroVigil has launched its iBrain personal brain monitor in the U.S., a noninvasive device that records brain electrical activity in individuals with neurological conditions. The device, based on electroencephalogram (EEG) technology, can be used at home and during sleep for efficient and user-friendly EEG data collection. In the second phase, a smaller version will be used to detect signs of Parkinson's disease.

Application:-

Disease Diagnosis segment is the fastest-growing segment in Electroencephalography Devices market share

The disease diagnosis segment is the fastest-growing segment in the electroencephalography devices market share and is expected to hold the market share over the forecast period.

The Global Electroencephalography (EEG) Devices Market is driven by the need for early diagnosis and monitoring of various neurological conditions. EEG devices are used for detecting epilepsy, Alzheimer's, Parkinson's, stroke, and brain tumors. They also aid in diagnosing sleep disorders like insomnia and obstructive sleep apnea by monitoring brain activity during sleep cycles. The increasing prevalence of these disorders and the focus on early detection and personalized treatment have driven the demand for advanced EEG systems, including portable and wearable devices. This underscores the crucial role of EEG in improving neurological healthcare outcomes globally.

For instance, in December 2024, LVIS Corporation has launched NeuroMatch Access, a cloud-based SaaS platform designed to streamline EEG diagnostics review and improve physician collaboration. The platform, now available in the US, enables neurologists to quickly review and interpret EEG data, enabling real-time collaboration for more accurate and timely diagnoses. NeuroMatch, a cutting-edge technology that uses artificial intelligence to remove unwanted artifacts, enables clinicians to visualize and understand brain circuit communication pathways, facilitating targeted interventions and restorative strategies to enhance neurological health.

Geographical Analysis

North America is expected to hold a significant position in the Electroencephalography Devices market share

North America holds a substantial position in the electroencephalography devices market and is expected to hold most of the market share due to advanced healthcare infrastructure and increasing prevalence of neurological disorders like epilepsy, Alzheimer's, and Parkinson's. Demand for EEG devices is driven by high awareness of early diagnosis and treatment, company's partnerships, government and private funding for neuroscience research, widespread adoption of advanced devices like portable and wearable EEG systems, and ongoing innovation in AI and machine learning integration.

For instance, in January 2024, Gate Neurosciences has partnered with Beacon Biosignals to advance the use of electroencephalogram (EEG) biomarkers in neuropsychiatry and cognition. The collaboration will use Beacon Biosignals' Dreem 3S headband device and neurobiomarker platform to conduct exploratory EEG and sleep analyses in depressed patients enrolled in Gate's Phase 2 trial of zelquistinel, a rapid-acting, once-weekly oral NMDA receptor positive modulator for treating major depressive disorder.

Europe is growing at the fastest pace in the Electroencephalography Devices market

Europe holds the fastest pace in the electroencephalography devices market and is expected to hold most of the market share due to a increased healthcare investments and focus on mental health and neurological research. The increasing incidence of neurodegenerative diseases and sleep disorders in the aging population necessitates advanced diagnostic tools like EEG. Government initiatives and research grants are also driving this growth. The adoption of digital health solutions and home-based and telehealth monitoring further supports the EEG market expansion.

For instance, in December 2024, Neuroelectrics and Neuronostics have partnered to offer an integrated EEG solution for pharmaceutical, contract research organisations, and academic partners. The partnership combines Neuroelectrics' advanced EEG hardware with Neuronostics' proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research. The platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are efficient and impactful. This partnership addresses the critical need for high-quality, actionable data in clinical trials.

Competitive Landscape

The major global players in the electroencephalography devices market include Natus Medical Incorporated, Compumedics Limited, Nihon Kohden Corporation, Medtronic plc, Neurosoft, Micromed Group, Cadwell Industries, Inc, Electrical Geodesics, Inc (Philips Healthcare) Brain Products GmbH, Advanced Brain Monitoring, Inc and among others.

Key Developments

In May 2024, ChristianaCare has introduced an innovative EEG brain monitoring program, a first of its kind, which can be performed at the bedside to measure brain electrical activity, providing vital signs for brain function and enabling quicker diagnosis of seizures.
In January 2024, Aditxt, a health innovation company, has acquired a portfolio of EEG brain monitoring technologies and devices, formerly owned by Brain Scientific. The acquisition will help shape the neurology monitoring market and shape its dynamic landscape for neurological care.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electroencephalography devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by Technology
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Skilled Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Portable EEG Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Standalone EEG Devices
6.4. Wearable EEG Devices
6.5. Wireless EEG Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Disease Diagnosis*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Monitoring
7.4. Research

8. By Technology

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
8.2. Digital EEG*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Analog EEG

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Centers
9.4. Ambulatory Surgical Centers
9.5. Research Institutes
9.6. Home Healthcare

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Natus Medical Incorporated*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Compumedics Limited
12.3. Nihon Kohden Corporation
12.4. Medtronic plc
12.5. Neurosoft
12.6. Micromed Group
12.7. Cadwell Industries, Inc.
12.8. Electrical Geodesics, Inc (Philips Healthcare)
12.9. Brain Products GmbH
12.10. Advanced Brain Monitoring, Inc

LIST NOT EXHAUSTIVE

12. Appendix

12.1 About Us and Services
12.2 Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球脑电图设备市场 - 2025 - 2033

Global Electroencephalography Devices Market - 2025 - 2033

市场动态：

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：依产品类型

第 7 章：按申请

第 8 章：按技术

第 9 章：最终用户

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 12 章：附录